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The 2013 Nobel Prize in Physiology or Medicine honors 
three scientists, James Rothman, Randy Schekman and 
Thomas Südhof, whose work revealed the mystery of the 
vesicle trafficking, i.e., how cells, from yeast to mammals,  
organize their transport systems. In a neuroscience perspec-
tive, this decades-long story might be described as a legend 
of identifying the SNARE complex and synaptotagmin pro-
teins, revealing their functional mechanisms, and shedding 
an insight into synaptic transmission. Their research un-
masked the exquisitely precise control of synaptic vesicle 
fusion. Here I will only review the history of how their pio-
neer work on vesicle fusion machinery served as a major 
step forward in our understanding of neuronal signaling. 
Classical physiological studies revealed the central im-
portance of synapses in brain function, indicating that neu-
rons communicate between each other primarily by chemi-
cal transmission at the synapse. Synaptic function is crucial 
for the brain to mediate intelligence, feelings and behavior. 
Most neuronal and mental diseases such as schizophrenia, 
depression, bipolar disorder and many other pathological 
conditions attribute to synaptic defects. Through their dis-
coveries, three scientists greatly advanced our understand-
ing of neuronal information processing. 
However, it is not an overnight thing—as Rothman de-
scribed their achievements—most of it has been accom-
plished and developed over many years, if not decades. In-
deed, it is a legend with many trials and tribulations. This 
actually was a decades-long legend of a group of scientists 
who have extraordinary courage, determination, vision, and 
insight, in searching for this synaptic vesicle fusion ma-
chinery. 
In mid-1970s, the general picture drawn by the pioneers 
of cell biology was that cells bustle with transport activities, 
multiple types of small bubble-like organelles called vesi-
cles ferry cellular substances from one site to another, pos-
sibly via well-designated targeting pathways [1]. Some ves-
icles that shuttle between organelles had been revealed and 
even mapped in the pathway of membrane budding or fus-
ing [13]. In the neuroscience field, it was found that nerve 
cells (or neurons) communicate with each other through 
specialized contact points called synapses. The synapse al-
lows a neuron to transmit an electrical or chemical signal to 
another cell. As early as 1951, Bernard Katz demonstrated 
that a chemical transmitter is released from a structure at the 
end of the neuron, called the presynaptic nerve terminal, to 
the outside of the neuron in a quantized fashion [4,5]. The 
quantum-like signal was later found to be due to the secre-
tion of multiple neurotransmitter molecules from a packet 
organelle called the “synaptic vesicle” in the nerve terminal 
[1]. Bernard Katz’s another finding was that neurotransmit-
ter releasing is highly regulated in response to Ca2+ influx 
into the presynaptic terminal [6]. This influx occurs when 
Ca2+ channels open in response to an electrical signal, called 
the action potential that is conducted to the nerve terminal 
[7]. For this work, Bernard Katz and George Palade were 
awarded the Nobel Prize one after another in 1970 and 1974. 
However, no one ever understood how vesicles budded 
from membranes; how vesicles knew their targets; and how  
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vesicles were fused with their target membranes. These 
questions were complex and challenging for most cell biol-
ogists and neuroscientists, but to the young and fearless 
scientists, James Rothman, Randy Schekman and Thomas 
Südhof, the questions seemed to be more captivating be-
cause they never lacked ideas and courage to try something 
new and figure it out. 
Both Rothman and Schekman decided to start with sim-
ple system as junior faculties in the late 1970s. Rothman 
tried to decompose the pathway by reducing vesicular 
transport to a set of elementary biochemical reactions and 
reconstitute it from the minimum number of components for 
budding and fusion in a test tube, while Schekman selected 
the way of genetic screening on the yeast Saccharomyces 
cerevisiae to obtain mutants that exhibit dysfunction in ves-
icle transport [8,9]. When they tried to track down the mo-
lecular machinery that performs the crucial trafficking func-
tions, most of their colleague scientists were skeptical. 
Schekman, a biochemist himself, proposed to use yeast ge-
netics to identify cellular trafficking components but he had 
no experience with yeast; Rothman tried to reconstitute 
from the minimum number of components of the budding 
and fusion machinery in a test tube by ignoring the compli-
cated, multi-step biological processes, including those in-
volved in DNA transcription and protein synthesis as part of 
the pathway. Furthermore, most scientists were arguing that 
breaking open the cells would destroy the spatial relation-
ships, and the appropriate membranes might never restore 
their relative positions in the cells. People also questioned 
whether yeast had a robust secretion system and whether 
findings from such a single-celled creature were applicable 
to animals, especially to the mammalian central nervous 
system. 
Regardless of the argument, Schekman and his graduate 
student, Peter Novick started the first experiment. They 
used a temperature-sensitive mutation strategy—raising the 
temperature would make a protein nonfunctional—to screen 
out the key genes required for secretion. The initial logic of 
this strategy is simple: the vesicle transport system is crucial 
for yeast to survive, the mutation in the crucial trafficking 
genes would cause a lethal phenotype [10]. Using electron 
microscopy, Schekman found that the mutants enhanced 
perturbations in the transport pathway. Some, for example, 
accumulated vesicles that presumably failed to fuse with 
their target membranes [10]. The ease of genetic manipula-
tion and a successful strategy gave rise to the identification 
of the first 23 key intracellular trafficking related genes 
(“sec”) including 13 genes relevant to membrane fusion, 
and led to the discovery of an array of novel proteins in-
volved in the secretory pathway, thus providing new in-
sights into the molecular machinery that mediates vesicle 
budding and fusion [11]. 
Rothman’s group used mutant mammalian cells and in-
vestigated vesicle trafficking by detecting the transport of a 
protein between membrane-bound compartments in a 
cell-free extract. Because people at that time were unable to 
express cloned genes in animal cells, they introduced the 
vesicular stomatitis virus (VSV) infection to mediate mem-
brane protein expression and thus successfully built a test 
tube system for studying vesicle trafficking [12]. They mixed 
two homogenates: one of which contained a VSV-infected 
protein in a partially assembled form due to the lack of an 
essential transferase (the donor, made from mutant host 
cells); the other had no VSV infection but contained the 
radioactively tagged transferase (the acceptor, made from 
wild-type cells). If vesicles carrying the VSV-infected pro-
tein were to bud off the membrane from the donor homog-
enate, and then fused with the membrane from the acceptor 
homogenate, the radioactively tagged transferase could be 
incorporated into the proteins just arrived, completing the 
assembly—in this way, any membrane traffic could be 
monitored by detecting the destined radioactive protein in 
the test tube. This approach was soon proved to be success-
ful and led to the finding of the fundamental principle, 
transport depends on the intrinsic chemical specificity of the 
membranes involved, rather than on the proximity of com-
partments [13]. Moreover, Rothman’s group used this in-
genious and powerful design to massively tease apart the 
proteins involved in vesicle budding and fusion [14]. 
A milestone in revealing the principle of membrane fu-
sion is the identification of the SNARE complex. This story 
began in 1987 with the finding in Rothman’s lab that 
cell-free transport is blocked by low concentrations of the 
sulfhydryl alkylating reagent N-ethylmaleimide (NEM). 
Then they purified the target of NEM and named it as 
N-ethylmaleimide-sensitive factor (NSF) based on its ability 
to rescue the NEM-poisoned reaction [15,16]. When Roth-
man tracked down the gene that encodes NSF and se-
quenced it, he found it was the mammalian homologue of a 
previously cloned yeast gene SEC18, one that Schekman 
had isolated in his earlier experiments [10,17]. It was the 
first convergence of genetics and biochemistry between 
these two independent groups, suggesting that NSF/Sec18p 
was required for fusion even in such distantly related crea-
tures as yeast and mammals. This boasted victory convinced 
many skeptics that both approaches were able to generate 
valuable insights and that in general, natural evolution in 
secretion system seems to be inherently robust. Although 
fusion needs NSF, but this protein cannot promote that re-
action on its own. Later, Rothman found that NSF is only a 
cytosolic protein that binds to membranes by means of the 
soluble NSF attachment protein (SNAP) and the SNAP gene 
turned out to resemble another one of Schekman’s screened 
genes, SEC17, which was found to be important for vesicle 
fusion [18]. In order to deeply dig into how SNAP and NSF 
work, Rothman proposed to search for the membrane re-
ceptors of SNAP, which he called the SNAP receptor, or 
SNARE. Guided by Schekman’s pioneer work of genetic 
screening, two SNARE components on the cytoplasmic 
membrane, SNAP-25/Sec9p and syntaxin-1/Sec5p were 
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soon cloned and Rothman demonstrated that these proteins 
form a complex and he named it as t-SNARE [19]. 
In the late 1980s and independently, Südhof set out to 
unveil the molecular underpinnings of the synaptic vesicle 
fusion. He asked the following important questions to him-
self, as always, immediately after he set up his lab in the 
University of Texas Southwestern Medical Center: How do 
the synaptic vesicle and the plasma membrane fuse in a mil-
lisecond time scale during synaptic transmission? How does 
calcium trigger synaptic vesicle fusion? How is calcium 
influx localized to the released sites in order to enable the 
fast coupling of an action potential to transmitter release? 
Südhof combined membrane protein biochemistry with 
molecular biology techniques to study synaptic vesicles and 
the key proteins and soon isolated the vesicle-associated 
membrane protein (Richard Scheller named it VAMP and 
obtained it from the electric organ of a marine ray a year 
ago and Rothman named it as v-SNARE) from mammalian 
brain and called it synaptobrevin [20]. Furthermore, Südhof, 
in collaboration with Reinhard Jahn, discovered that 
VEMP/synaptobrevin/sec22p, SNAP-25/Sec9p and syntax-
in-1/Sec5p are the substrates for the proteolytic activities of 
botulinum and tetanus toxins, which were known to block 
neurotransmitter release [21,22]. The identification of these 
three SNARE components and the relevant functional anal-
ysis provided the most important insight into the principle 
of membrane fusion, for which Rothman summarized as 
follows: the t-SNARE and v-SNARE components wrap 
around each other, thus to pull together the membranes in 
which they are embedded, thus prompting fusion [19]. 
As a neuroscientist, Südhof was fascinated by the ultra-
fast synaptic vesicle fusion which dictates precise neural 
signaling. Classical physiological work revealed the central 
importance of synapses in brain function, and characterized 
the mechanisms involved in synaptic transmission. He 
thought that Bernard Katz’s discovery should not be a bril-
liant finale, but an opening of a revolutionary era of neuro-
science—the era to elucidate how synapses work at the mo-
lecular level. In the line of calcium-dependent quantal re-
lease proposed by Katz, a delay in a microsecond time scale 
between calcium influx and neurotransmitter release would 
not allow the occurring of a cascade of protein-protein in-
teractions. Therefore, there should be only a small number 
of molecules, or possibly a single molecule, to sense and 
trigger the fusion. 
The cloning of a vesicle-associated protein called synap-
totagmin-1 (syt-1) by Südhof and Jahn in 1990 was the 
turning point of the research [23]. Initially, Syt-1 was 
thought to be an evolutionarily conserved transmembrane 
protein with two cytoplasmic C2 domains, which represent 
the ‘second constant sequence’ in protein-kinase C iso-
zymes [24]. However, it was later found to bind to phos-
pholipids and perform calcium-dependent activities [23]. 
More importantly, Syt1 C2 domains can also bind to syn-
taxin-1 and the SNARE complex [25]. The new discovery 
of biochemical properties of Syt1 lead Südhof to speculate 
that syt-1 and/or some other protein family members might 
be the long-sought calcium sensor(s) for neurotransmitter 
release [26]. He kept decades-long focus on the systematic 
study of synaptotagmin protein family thereafter [27]. He 
carried out a series of biochemical studies on interactions 
between syt-1 and an array of presynaptic proteins [28]. In 
collaboration with structural biologists, he obtained the 
atomic structures of calcium-free and calcium-bound wild 
type and mutant Syt-1 C2 domains and provided the first 
insight into how the C2 domains bind to calcium [29]. 
Südhof pioneered the use of genetically modified mice to 
examine the functions of these key proteins and the ma-
chinery that regulates the calcium-dependent neurotrans-
mitter releasing. His lab created a large number of genet-
ically modified mice with the genes encoding synaptotag-
mins being knocked out or mutated and systematically re-
vealed several important evidences. The in vivo study in his 
lab demonstrated that Syt1 knockout abolished the fast 
synchronous transmitter release and the mutation that 
changes the calcium affinity of endogenous Syt1 also al-
tered the calcium-dependent synchronous neurotransmitter 
release to the same extent [3032]. These conclusions were 
reached based on the fact that the synaptotagmin 
knock-out/mutations caused neither impairment in calcium 
influx into the nerve terminal nor the disturbance of the spa-
tial coupling between calcium channels and vesicles [32]. 
Furthermore, they found that only three synaptotag-
mins—Syt1, Syt2 and Syt9—mediate fast synaptic vesicle 
exocytosis. Most forebrain neurons express only Syt1, 
whereas Syt2 is the predominant calcium sensor of very fast 
synapses in the brainstem, and Syt9 is primarily present in 
the limbic system. Only these isoforms of synaptotagmin 
were able to rescue the fast synchronous component of 
transmitter release in syt-1 deficient neurons [33]. All the 
results lead to the plausible mechanism that synaptotagmin 
functions as the calcium sensor and once calcium-binding 
sites of Synaptotagmin C2 domain are occupied, the calci-
um-activated synaptotagmin interacts with SNARE com-
plex, thereby triggering synaptic vesicle fusion [32]. 
By ingeniously and elegantly designed experiments, 
these three scientists systematically exposed and analyzed 
the cascades of presynaptic protein-protein interactions in-
volved in membrane fusion and gave an insight into the 
molecular mechanism that governs neurotransmitter release 
with precision. Nevertheless, many new questions now arise, 
which are not just details but of great importance. For ex-
ample, what are the precise physicochemical mechanisms 
underlying the fusion process, and what defects of the fu-
sion process would cause brain diseases? Much remains to 
be done in this field. A central goal of neuroscience is to 
understand the cell biology and biochemistry of the synapse, 
and to help us explain who we are, how we became who we 
are, and how we function moment by moment [34]. These 
three scientists’ work made a great step forward to these 
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goals, but their discovery should not be considered as a bril-
liant finale, but an opening of a new era of neuroscience. 
The legend of synapse study is still ongoing, people will 
further reveal the elaborate orchestrations underlying our 
sophisticated neurobiological activities, to understand the 
nature of thought and the identity of ourselves.  
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